Chuan Xu

21PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 23, 2026
Unveiling Lactylation: A Novel Frontier in Cancer Stemness and Therapy.

|Jan 29, 2026
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan.

Jing Xu, Jing Liu, Yang Liu

|Jan 22, 2026
Intratumoral Lactobacillus johnsonii Enhances Sensitivity to PD-1 Blockade by Inducing CD8+ T-cell Expansion in Hepatocellular Carcinoma.

Qianshi Liu, Yiqiang Liu, Yue Zhou

|Sep 23, 2025
TSH Ligand-Based CAR-T Cell Effectively Eradicates TSHR-Positive Thyroid Cancer with Favorable Safety Profile.

Fei Wang, Hui Zuo, Li Liu

|Jul 03, 2025
Impaired autophagy by cepharanthine induces immunogenic cell death and enhances anti-PD-1 response in MSS-type colorectal cancer.

Ming Zhao, Juan Nie, Ao Ye

|Oct 08, 2024
Correction: PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3.

Lanlin Hu, Mingxin Liu, Bo Tang

Pageof 4

Frequent Collaborators

4 joint publications

Mingxin Liu

4 joint publications

Hong Wu

3 joint publications

Zhaoshen Li

3 joint publications

Zhi-Xiong Jim Xiao